EPHEDRINE sulfate injection solution

Land: USA

Språk: engelsk

Kilde: NLM (National Library of Medicine)

Aktiv ingrediens:

Ephedrine Sulfate (UNII: U6X61U5ZEG) (Ephedrine - UNII:GN83C131XS)

Tilgjengelig fra:

Cantrell Drug Company

INN (International Name):

Ephedrine Sulfate

Sammensetning:

Ephedrine Sulfate 10 mg in 1 mL

Resept typen:

PRESCRIPTION DRUG

Autorisasjon status:

unapproved drug other

Preparatomtale

EPHEDRINE- EPHEDRINE SULFATE INJECTION, SOLUTION
CANTRELL DRUG COMPANY
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
EPHEDRINE SULFATE 10 MG/ML IN 0.9% SODIUM CHLORIDE 5 ML SYRINGE
EPHEDRINE
ephedrine sulfate injection, solution
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:52533-118
ROUTE OF ADMINISTRATION
INTRAVENOUS
Cantrell Drug Company
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
EPHEDRINE SULFA TE (UNII: U6 X6 1U5ZEG) (Ephedrine - UNII:GN8 3C131XS)
Ephedrine Sulfate
10 mg in 1 mL
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
SO DIUM CHLO RIDE (UNII: 451W47IQ8 X)
7.2 mg in 1 mL
WATER (UNII: 0 59 QF0 KO0 R)
OTHER INGREDIENTS
INGREDIENT KIND
INGREDIENT NAME
QUANTITY
May co ntain
SULFURIC ACID (UNII: O40 UQP6 WCF)
May co ntain
SO DIUM HYDRO XIDE (UNII: 55X0 4QC32I)
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:52533-118 -
15
5 mL in 1 SYRINGE, PLASTIC; Type 0 : No t a Co mbinatio n
Pro duc t
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 3/18 /20 16
LABELER -
Cantrell Drug Company (035545763)
REGISTRANT -
Cantrell Drug Company (035545763)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
Cantrell Drug
Co mpany
0 3554576 3
manufacture(52533-118 ) , human drug co mpo unding o utso urcing
facility(52533-118 ) (No intent to
co mpo und 50 6 E (drug sho rtage) drugs), (No t co mpo unding fro m
bulk ingredient)
Revised: 3/2016